Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Bayer ag – product pipeline review – 2012


Published on

2012 || Bayer AG – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

Bayer ag – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Bayer AG – Product Pipeline Review – 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Market Direct’s pharmaceuticals report, “Bayer AG - Product Pipeline Review- 2012” provides data on the Bayer AG’s research and development focus. Thereport includes information on current developmental pipeline, complete with latestupdates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Bayer AG’s corporate website, SEC filings, investorpresentations and featured press releases, both from Bayer AG and industry-specificthird party sources, put together by Global Markets Direct’s team.Scope- Bayer AG - Brief Bayer AG overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Bayer AG human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 13
  2. 2. List of Figures 16Bayer AG Snapshot 17Bayer AG Overview 17Key Information 17Key Facts 17Bayer AG – Research and Development Overview 18Key Therapeutic Areas 18Bayer AG – Pipeline Review 23Pipeline Products by Stage of Development 23Pipeline Products – Monotherapy 24Pipeline Products – Combination Treatment Modalities 25Bayer AG – Pipeline Products Glance 26Bayer AG – Late Stage Pipeline 26Registration Filed Products/Combination Treatment Modalities 26Phase III Products/Combination Treatment Modalities 27Bayer AG Clinical Stage Pipeline Products 29Phase II Products/Combination Treatment Modalities 29Phase I Products/Combination Treatment Modalities 32Bayer AG – Early Stage Pipeline Products 34Pre-Clinical Products/Combination Treatment Modalities 34Bayer AG – Drug Profiles 35Alpharadin 35Product Description 35Mechanism of Action 35R&D Progress 35Amikacin Inhale 37Product Description 37Mechanism of Action 37R&D Progress 37Autologous FL Vaccine 39Product Description 39Mechanism of Action 39R&D Progress 39BAY 1000394 40Product Description 40Mechanism of Action 40
  3. 3. R&D Progress 40BAY 1002670 41Product Description 41Mechanism of Action 41R&D Progress 41BAY 80-6946 42Product Description 42Mechanism of Action 42R&D Progress 42BAY 80-6946 + Paclitaxel 43Product Description 43Mechanism of Action 43R&D Progress 43Eylea 72Product Description 72Mechanism of Action 72List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1Ardea Biosciences, Inc. – Product Pipeline Review – 2012Astellas Pharma Inc. – Product Pipeline Review – 2012
  4. 4. Bayer AG – Product Pipeline Review – 2012BioLineRx, Ltd. – Product Pipeline Review – 2012Cytokinetics, Incorporated – Product Pipeline Review – 2012Meda AB – Product Pipeline Review – 2012Medivir AB – Product Pipeline Review – 2012Nektar Therapeutics – Product Pipeline Review – 2012Novo Nordisk A/S – Product Pipeline Review – 2012SciClone Pharmaceuticals, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585
  5. 5. Email: